【レポートの概要（一部）】
1. Report Overview
1.1 Global Generic Drugs: Market Overview
1.2 Global Generic Drugs Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered By This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. An Introduction to Generic Drugs
2.1 An Introduction to the Rise of Generic Drugs
2.2 What Are Generic Drugs?
2.2.1 Generic Active Ingredients
2.3 A Brief Overview of the Pharmaceutical Industry
2.3.1 Brief History of Generic Drugs
2.3.2 The Hatch-Waxman Act: The Rise of Generics
2.4 Demonstrating Bioequivalence: A Major Factor in Approving Generics
2.5 Types of Generics – Authorised, Branded and Unbranded
2.6 Complex Generics
2.7 Classification of Generic Drugs Markets
2.8 Is Generic Substitution Bad News for Big Pharma Business?
2.8.1 The ‘Evergreening’ of Pharmaceutical Products
2.9 Regulation of Generic Drugs
2.9.1 Regulation in the US
2.9.2 Regulation in Europe
2.9.3 Regulation in Japan
2.9.4 Regulation in China
2.10 Compulsory Licensing
2.11 Market Definition and Scope of This Report
2.11.1 Market Sizing and Revenue Reporting
2.11.2 Currency Exchange Rates in This Report
3. Generic Drugs Market 2016-2026
3.1 The Global Generic Drugs Market: Market Overview
3.1.1 Segmenting the Global Generic Drugs Market
3.2 The Rise of the Global Generic Drugs Market in 2015
3.3 Changes in the Regional Distribution of the Generic Drugs Market 2014-2015
3.4 The Global Generic Drugs Market: Sales Forecast 2016-2026
3.5 Generic Drugs: Regional Market Forecast: 2016-2026
3.5.1 Changes in Generic Drug Regional Market Shares 2016-2026
3.6 Leading National Markets for Generic Drugs: Market Forecast 2016-2026
3.7 National Markets that will Drive Generic Drugs Growth
3.8 Changes in Market Shares by National Market 2016-2026
3.9 Drivers and Restraints for the Global Generic Drugs Market 2016-2026
4. US Generic Drugs Market, 2016-2026
4.1 Generic Drugs in the US: Market Overview
4.1.1 The Effects of Generics on Healthcare Spending in the US
4.1.2 The Hatch-Waxman Act and Its Ongoing Effects
4.1.3 Consolidation in the Drug Development and Supply Chain Driving US Generics
4.2 US Historical Generic Penetration Rates
4.3 Leading Companies Operating within the US Generic Drugs Market
4.3.1 The Increasing Acceptance of Generics amongst Consumers
4.3.2 Affordable Care Act: Expanding Medicare Coverage
4.4 The US Generic Drugs Market: Drivers and Restraints 2016-2026
4.5 The US Generic Drugs Market Forecast: 2016-2026
4.6 The US Generic Drugs Market – Strategic Analysis
4.6.1 Will Biosimilars Dictate the Future of the US Generics Market?
4.6.2 The Backlog of ANDA Applications
4.6.3 The Generic Drug User Fee Amendments (GDUFA)
4.6.4 Shortages of Generic Drugs Will Restrain the Market
4.6.5 The Anti-Competitive ‘Pay for Delay’ Effect
4.7 US Generic Drugs Market: A Range of Factors Contributing to Growth
5. Leading European Generic Drug Market, 2016-2026
5.1 European Generic Drugs: Market Overview
5.1.1 The EU5
5.1.2 Why Growth in Some Markets is Being Hindered?
5.1.3 Predominant Pricing Systems and Generic Penetration In European Markets
5.1.4 Will Europe Move towards Free-Pricing Systems?
5.1.5 Challenges in the European Regulatory Environment
5.1.6 Ending Anti-Competitive ‘Pay for Delay’ Tactics in Europe
5.1.7 FDA and EMA Joint Data Sharing and Inspections
5.2 EU5 Generic Drugs Market Forecast: 2016-2026
5.3 EU5 Market Share Breakdown 2016-2026
5.4 Germany: New Reforms to Medicinal Pricing May Impact Market Entry
5.4.1 German Generic Drugs Market: Generic Penetration By Volume, 2000-2015
5.4.2 German Generic Drugs Market: Generic Penetration by Value, 2000-2015
5.5 UK Generic Drugs Market: A Mature Market with Growth Potentials
5.5.1 UK Generic Drugs Market: Sales Forecast 2016-2026
5.5.2 Cost Pressures and Demand-Side Policies Drive UK Generic Penetration
5.5.3 UK Generic Drugs Market: Generic Penetration by Volume, 2000-2015
5.5.4 UK Generic Drugs Market: Generic Penetration by Value, 2000-2015
5.5.5 Pharmacists as Enforcers of Generic Substitution
5.5.6 Pay Time for ‘Pay-For-Delay’
5.5.7 GSK: Widening the Gate to Accessible Medicines
5.6 French Generic Drugs Market: Healthcare Reforms Impacting on Market Growth
5.6.1 French Generic Drugs Market: Sales Forecast 2016-2026
5.6.2 French Generic Drugs Market: Generic Penetration by Volume, 2000-2015
5.6.3 French Generic Drugs Market: Generic Penetration by Value, 2000-2015
5.7 Italian Generic Drugs Market: Branded Generics Hindering Overall Growth
5.7.1 The Tightening of Italy’s Patent Legislations
5.7.2 The Italian Healthcare System – A Tale of Falling Budgets
5.7.3 Italian Generic Drugs Market: Sales Forecast: 2016-2026
5.7.4 Italian Generic Drugs market: Generic Penetration by Volume
5.7.5 Italian Generic Drugs Market: Generic Penetration by Value
5.8 Spain
5.8.1 Cost-Containment Measures Helping to Boost Generic Drug Use
5.8.2 Spanish Generic Drugs Market: Sales Forecast 2016-2026
5.8.3 Spanish Generic Drugs Market: Generic Penetration by Volume, 2000-2015
5.8.4 Spanish Generic Drugs Market: Generic Penetration by Value, 2000-2015
6. Asia-Pacific Generic Drugs Market, 2016-2026
6.1 Generic Drugs in the Asia-Pacific Market: Market Overview
6.2 Chinese Generic Drugs Market: Domestic Companies Dominate the Market Landscape
6.2.1 The Major Drivers of Growth in the Chinese Generics Market
6.2.2 Chinese Generic Drugs Market: Sales Forecast 2016-2026
6.2.3 Compulsory Licensing of Generic Drugs
6.2.4 Expansion of Healthcare Coverage and Reimbursement
6.2.5 Chinese Generic Drugs Market: Generic Penetration by Volume, 2000–2015
6.2.6 Chinese Generic Drugs Market: Generic Penetration by Value, 2000-2015
6.2.7 The Impacts of Price Controls and the Anhui Model
6.3 Japanese Generic Drugs Market: High Barriers to Entry
6.3.1 Public Perception of Generics in Japan
6.3.2 Japanese Generic Drugs Market: Leading Companies
6.3.3 Japanese Generic Drugs Market: Sales Forecast 2016-2026
6.3.4 Japanese Generic Drugs Market: Generic Penetration by Volume, 2000–2015
6.3.5 Japanese Generic Drugs Market: Generic Penetration by Value, 2000-2015
6.3.6 Government Initiatives Driving Generic Penetration
6.3.7 Japanese Attitudes to Generic Drugs
6.4 Indian Generic Drugs Market: Regulatory Failures Hindering Sales Growth
6.4.1 Leading Companies in the Indian Generic Drugs Market
6.4.2 Indian Generic Drugs Market: Sales Forecast 2016-2026
6.4.3 The Reforms to India’s Drug Prices Control Order and Its Likely Effects on Generic Drugs Revenues
6.4.4 Expansion of the National Healthcare Coverage Increases the Need for Generics
6.4.5 Has Recent Manufacturing Quality Failures Dented India’s Generics Growth?
7. Emerging Generic Drugs Market, 2016-2026
7.1 Generic Drugs in the Emerging Market: Market Overview
7.1.1 Emerging Economies: Improving Logistics and Better Infrastructure Catalysing Generics Growth
7.2 Brazil
7.2.1 Brazilian Generic Drugs Market: Sales Forecast 2016-2026
7.2.2 Generics to Facilitate Low-Income Earner’s Access to Medicines
7.2.3 Foreign Generic Drug Manufacturers Entering the Brazilian Market
7.3 Russian Generic Drugs Market: Improving IP Protection to Aid Market Growth
7.3.1 Historical Trends in Russia’s Pharmaceutical Production and Distribution
7.3.2 The Pharma2020 Strategy – Healthcare and Industry Reform
7.3.3 Self-Medication in Russia and the Integral Role of Pharmacies
7.3.4 Russian Generic Drugs Market: Sales Forecast 2016-2026
7.4 Mexico
7.4.1 Government Programmes to Vitalise Generic Penetration in Mexico
7.4.2 Regulatory Changes and the Inception of COFEPRIS
7.4.3 Mexican Generic Drugs Market: Sales Forecast 2016-2026
7.5 South Korea
7.5.1 Pharmaceutical Price Controls and Measures Being Implemented in South Korea
7.5.2 South Korean Generic Drugs Market: Sales Forecast 2016-2026
7.6 Turkey
7.6.1 Cost Cutting Measures and their Effects on Turkish Generics
7.6.2 Will Turkey Become a Production Base for High Technology Products?
7.6.3 Turkish Generic Drugs Market: Sales Forecast 2016-2026
7.6.4 Regulatory Guidelines for Generic Drugs in Turkey
7.6.5 How Effective has Turkey’s Health Transformation Programme Been?
8. Leading Companies in the Generic Drugs market, 2016-2026
8.1 Generic Drugs: Continuous Expansion to Rival
8.1.1 The Leading Companies in the Global Generics Market
8.2 Teva
8.2.1 Teva: Historical Financial and Performance Analysis, 2010-2014
8.2.2 Teva Generic Drugs Sales Forecast 2016-2026
8.2.3 Teva and Allergan Spin-Off Generic Drug Deal
8.2.4 Allergan: Historical Financial and Performance Analysis, 2010-2014
8.2.5 Allergan: Developments in Generic Drug Segment Prior Mega-Deal
8.2.6 Teva: Generic Drugs Portfolio Analysis, 2016
8.2.7 Teva: What Future Moves Could We Expect?
8.3 Novartis
8.3.1 Novartis: Historical Financial and Performance Analysis, 2010-2014
8.3.2 Novartis Generic Drugs Sales Forecast 2016-2026
8.3.3 Novartis Generic Drugs Portfolio Analysis, 2016
8.3.4 What Does the Future Hold for Novartis’ Generic Drugs Business?
8.4 Mylan
8.4.1 Mylan: Historical Financial and Performance Analysis, 2010-2014
8.4.2 Mylan Generic Drugs Sales Forecast 2016-2026
8.4.3 Mylan: Recent Developments
8.4.4 Mylan’s Collaborative Efforts
8.4.5 What Does the Future Hold for Mylan’s Generic Drugs Business?
8.5 Pfizer
8.5.1 Pfizer: Historical Financial and Performance Analysis, 2010-2014
8.5.2 Pfizer’s Restructuring Strategy
8.5.3 Pfizer’s Done Deal with Hospira
8.5.4 Pfizer Generic Drugs Sales Forecast 2016-2026
8.5.5 Hospira: A Brief Overview of Operations
8.5.6 Hospira: Historical Financial and Performance Analysis 2010-2014
8.5.7 Hospira: Recent Developments
8.5.8 Future Prospects for Pfizer’s Generic Business
8.6 Abbott
8.6.1 Abbott: Historical Financial and Performance Analysis, 2010-2014
8.6.2 Abbott Generic Drugs Sales Forecast 2016-2026
8.6.3 Abbott: Recent Developments
8.6.4 What Does the Future Hold for Abbott’s Generic Drugs Business?
8.7 Sun Pharma
8.7.1 Sun Pharma’s Business Areas
8.7.2 Sun Pharma: Historical Financial and Performance Analysis, 2010-2014
8.7.3 Sun Pharma Generic Drugs Sales Forecast 2016-2026
8.7.4 Sun Pharma-Ranbaxy Acquisition
8.8 Aspen
8.8.1 Aspen: Historical Financial and Performance Analysis, 2010-2014
8.8.2 Aspen Generic Sales Forecast 2016-2026
8.8.3 Aspen: Recent Developments
8.8.4 Future Outlook for Aspen’s Generic Business
8.9 Fresenius Kabi
8.9.1 Fresenius Kabi: Historical Financial and Performance Analysis, 2010-2014
8.9.2 Fresenius Kabi Generic Drugs Sales Forecast 2016-2026
8.9.3 InnoPharma Licensing Deal Bolsters Portfolio Grown Via Past Acquisitions
8.9.4 Fresenius Kabi’s Joint Venture with PT Soho Global Health
8.9.5 Future Prospects for Fresenius Kabi’s Generics Business
8.10 Sanofi
8.10.1 Sanofi: Historical Financial and Performance Analysis, 2010-2014
8.10.2 Sanofi Generic Sales Forecast 2016-2026
8.10.3 Sanofi’s Response to Lantus Competition
8.10.4 Sanofi’s Strategies to Develop Generic Sales
8.10.5 Future Prospects for Sanofi’s Generics Business
9. Qualitative Analysis of the Generic Drugs Market, 2016-2026
9.1 Market Factors Influencing the Global Generic Drugs Market
9.2 SWOT Analysis of the Global Generic Drugs Market, 2016-2026
9.2.1 Strengths
9.2.2 Weaknesses
9.2.3 Opportunities
9.2.4 Threats
9.3 Porter’s Five Force Analysis of the Global Generic Drugs Market, 2016-2026
9.3.1 Power of Buyers: Medium
9.3.2 Power of Suppliers: Low
9.3.3 Rivalry among Competitors: High
9.3.4 Threat of New Entrants: High
9.3.5 Threat of Substitutes: Low
10. Conclusions
10.1 Overview of Current Market Conditions and Market Forecast, 2016-2026
10.2 Generic Drugs as a Strategic Tool in Healthcare
10.3 Major Drivers of Growth for Generic Drugs, 2016-2026
10.4 The Regulatory Landscape for Generic Drugs
10.5 Leading Generic Drug Manufacturers
10.6 Future Outlook for the Leading Regions within the Global Generic Drugs Market, 2016-2026
10.7 Generic Penetration by Volume in Leading National Markets
10.8 What Does The Future Hold For The Global Generic Drugs Market?
11. Glossary
【レポート販売概要】
■ タイトル：ジェネリック医薬品の世界市場予測2016-2026■ 英文：Generic Drugs Market Forecast 2016-2026
■ 発行日：2016年4月
■ 調査会社：visiongain
■ 商品コード：VGAIN60631
■ 調査対象地域：グローバル
- 世界のHFC冷媒市場2015The Global HFC Refrigerants Industry Report 2015 is a professional and in-depth study on the current state of the HFC Refrigerants industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The HFC Refrigerants market analysis is provided for the international markets including development trends, competitive la …
- 実験室（ラボ）オートメーションの世界市場予測（～2021年）：ロボティックアーム、マイクロプレートリーダー、LIMS、自動液体取扱い機The global lab automation market is projected to USD 5.48 Billion by 2021 from USD 3.92 Billion in 2016, growing at a CAGR of 6.9% from 2016 to 2021. In this report, the global lab automation market is broadly segmented by equipment and software, application, type, end user, and region. Major factors fueling market growth are such as process miniaturization, progressing drug discovery and clinical …
- 世界のE1/T1トランシーバー(LIU/Framer)市場2015The Global E1/T1 Transceivers (LIU/Framer) Industry 2015 Market Research Report is a professional and in-depth study on the current state of the E1/T1 Transceivers (LIU/Framer) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The E1/T1 Transceivers (LIU/Framer) market analysis is provided for the intern …
- ヨーロッパの組み立て式家具（RTA家具）市場：住宅用RTA家具、オフィス用RTA家具About RTA furniture RTA furniture, also known as flat-pack, knock-down (KD), DIY (do it yourself), self-assembly, or kit furniture, is a form of furniture requiring customers to assemble the product. This form of furniture is widely popular across Europe with customers who wish to save money by assembling the product at home or the office, reducing the delivery cost. Some of the top product offeri …
- 動物飼料用有機微量ミネラルの世界市場2019-2023About this market Organic trace minerals play a vital role in the metabolic wellbeing of animals as also support enzymatic reactions. A shortage of these nutrients may lead to low-feed efficiency an outbreak of diseases and inefficient growth. The various health benefits of organic trace minerals encourage breeders to feed their animals on organic trace mineral feed. Organic trace minerals enhance …
- 環境配慮型建築材料の世界市場分析：製品別（構造、外装、内装、その他）、用途別（フレーミング、断熱、屋根、外装、内装仕上げ、その他）、セグメント予測The global green building materials market size is expected to exceed USD 364 billion by 2022, according to a new report by Grand View Research, Inc. Rising consumer awareness regarding benefits of these products such as lower maintenance and operating costs is expected to propel demand for these components over the forecast period. Supportive regulatory policies favoring the use of green building …
- Alon USA Energy, Inc.：石油・ガスバリューチェーン分析レポート2013Alon USA Energy, Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Alon USA Energy, Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Alon USA Energy, Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report e …
- ドキュメント管理アウトソーシングの世界市場2016-2020About the Document Outsourcing Market In the era of digitalization and information economy, organizations adopt IT solutions for the effective management of large volumes of unorganized enterprise documents. Document management solutions are designed to manage routine files and paper-based documents through digital ECM systems. organizations require quick access to enterprise files and information …
- 製薬産業向け治験サプライ及び物流の世界市場2016-2026Services Supporting Clinical Trials – Discover Your 2016 Guide to That Industry’s Trends, Abilities and Revenue PotentialsWhat does the future hold for companies supplying and assisting clinical trials? Now you can gain data and revenue forecasts for that rising market, helping you stay ahead. Discover that industry’s financial prospects. From 2016 see what is possible. With our study you explore …
- 世界の静電集塵器市場：Global Electrostatic Precipitator Market 2014-2018TechNavio's analysts forecast the Global Electrostatic Precipitator market to grow at a CAGR of 9.42 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in government policies to reduce the emissions associated with coal-fired power generation. The Global Electrostatic Precipitator market has also been witnessing the shift towards developing …
- 世界主要国の風疹検査（医療機器）市場：サプライヤーシェア及び市場予測The report presents a detailed analysis of the Rubella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rubella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commerc …
- 有効栄養補助食品の世界市場展望2017-20276According to Stratistics MRC, the Global Active Nutraceutical Ingredients Market is to grow at a CAGR of 8.3% during the forecast period. Some of the key factors fueling the market are increasing health awareness among people and growing demand for healthy food. However, High costs involved in the R&D activities along with high price for fortified and enriched products hampers the market growth of …
- 透過キャッシングサービスの世界市場2015-2019About Transparent Caching Caching is the temporary storage of web content for faster subsequent access. Transparent caching is a solution that enables the service provider to offload a significant amount of content in a cached copy of the popular content close to the edge of the network, which is delivered to an end-user directly from the edge of the network rather than from the source. It is invi …
- 2014年市場分析：フランスの肝炎診断Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in France. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, A …
- レーザー技術の世界市場：固体レーザー、液体レーザー、ガスレーザーThe scope of this report covers the laser technology market on the basis of laser type, application, vertical, and geography. Solid lasers are leading in the market. The growth of the market is attributed to the ability of solid lasers to prevent material wastage when in the active medium and produce both continuous and pulsed output with greater efficiency. The major solid lasers include YAG lase …
